Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Giuseppe, Dattilo"'
Autor:
Francesco Loria, Pasquale Mone, Antonella Rispoli, Rosanna Di Fonzo, Daniele Masarone, Costantino Mancusi, Michele Correale, Antonio Vitullo, Michele Granatiero, Pietro Mazzeo, Valentina Mercurio, Francesco Fiore, Elena Di Sarro, Luigi Falco, Carmine Izzo, Alfonso Campanile, Nicola Virtuoso, Eugenio Stabile, Salvatore Bonanno, Giuseppe Dattilo, Carlo Gabriele Tocchetti, Gaetano Santulli, Carmine Vecchione, Michele Ciccarelli, Valeria Visco
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-14 (2024)
Abstract Background Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i) represent a deep revolution of the therapeutic approach to heart failure (HF), preventing its insurgence but also improving the management of the disease and slowing its natural p
Externí odkaz:
https://doaj.org/article/62f52253e5614fe6bd6042fb67dd5779
Autor:
Alberto Palazzuoli, Filippo Pirrotta, Alessandra Cartocci, Elvira Delcuratolo, Frank Loyd Dini, Michele Correale, Giuseppe Dattilo, Daniele Masarone, Laura Scelsi, Stefano Ghio, Carlo Gabriele Tocchetti, Valentina Mercurio, Natale Daniele Brunetti, Savina Nodari, Francesco Barillà, Giuseppe Ambrosio, Erberto Carluccio
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, Vol 18 (2024)
Background: Sacubitril/valsartan (S/V) is a cornerstone treatment for heart failure (HF). Beneficial effects on hospitalization rates, mortality, and left ventricular remodeling have been observed in patients with heart failure and reduced ejection f
Externí odkaz:
https://doaj.org/article/8b18708733c54096864b3b99da5d67ae
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction
Autor:
Alberto Palazzuoli, Paolo Severino, Andrea D’Amato, Vincenzo Myftari, Lucia Tricarico, Michele Correale, Giuseppe Dattilo, Francesco Fioretti, Savina Nodari
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 7, p 270 (2024)
Background: Heart failure with preserved ejection fraction (HFpEF) is a multifactorial condition with a variety of pathophysiological causes and morphological manifestations. The inclusion criteria and patient classification have become overly simpli
Externí odkaz:
https://doaj.org/article/cf4e3a46abb148f0bfa58364f205cdb0
Autor:
Michele Correale, Lucia Tricarico, Ester Maria Lucia Bevere, Francesco Chirivì, Francesca Croella, Paolo Severino, Valentina Mercurio, Damiano Magrì, Frank Dini, Roberto Licordari, Matteo Beltrami, Giuseppe Dattilo, Andrea Salzano, Alberto Palazzuoli
Publikováno v:
Biomolecules, Vol 14, Iss 5, p 552 (2024)
Pulmonary arterial hypertension (PAH) is a rare subtype of group 1 pulmonary hypertension (PH) diseases, characterized by high pulmonary artery pressure leading to right ventricular dysfunction and potential life-threatening consequences. PAH involve
Externí odkaz:
https://doaj.org/article/f5bd1b0986aa4efca5a94a3ce103b65d
Autor:
Antonio Parlavecchio, Giampaolo Vetta, Giovanni Coluccia, Lorenzo Pistelli, Rodolfo Caminiti, Manuela Ajello, Michele Magnocavallo, Giuseppe Dattilo, Rosario Foti, Scipione Carerj, Pasquale Crea, Michele Accogli, Gian Battista Chierchia, Carlo de Asmundis, Domenico Giovanni Della Rocca, Pietro Palmisano
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 49, Iss , Pp 101292- (2023)
Introduction: Rhythm control strategy in paroxysmal atrial fibrillation (AF) can be performed with antiarrhythmic drugs (AAD) or catheter ablation (CA). Nevertheless, a clear overview of the percentage of freedom from AF over time and complications i
Externí odkaz:
https://doaj.org/article/e01ebc70480c49b3b6d546e5240998e1
Autor:
Valeria Visco, Ilaria Radano, Alfonso Campanile, Amelia Ravera, Angelo Silverio, Daniele Masarone, Giuseppe Pacileo, Michele Correale, Pietro Mazzeo, Giuseppe Dattilo, Francesco Giallauria, Alessandra Cuomo, Valentina Mercurio, Carlo Gabriele Tocchetti, Paola Di Pietro, Albino Carrizzo, Rodolfo Citro, Gennaro Galasso, Carmine Vecchione, Michele Ciccarelli
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2909-2917 (2022)
Abstract Aims The angiotensin receptor‐neprilysin inhibitor (ARNI) sacubitril/valsartan (Sac/Val) demonstrated to be superior to enalapril in reducing hospitalizations, cardiovascular and all‐cause mortality in patients with ambulatory heart fail
Externí odkaz:
https://doaj.org/article/c2e8932710404f2085199d285c693376
Autor:
Roberto Licordari, Michele Correale, Salvatore Bonanno, Matteo Beltrami, Michele Ciccarelli, Antonio Micari, Alberto Palazzuoli, Giuseppe Dattilo
Publikováno v:
Biomolecules, Vol 14, Iss 3, p 309 (2024)
Heart failure (HF) represents a significant global health challenge, characterized by high morbidity and mortality rates, and imposes considerable burdens on healthcare systems and patient quality of life. Traditional management strategies, primarily
Externí odkaz:
https://doaj.org/article/9019bdd1ab73493aa5cee8d4dbd1d0e6
Autor:
Egidio Imbalzano, Luana Orlando, Giuseppe Dattilo, Marianna Gigliotti De Fazio, Giuseppe Camporese, Vincenzo Russo, Alessandro Perrella, Francesca Futura Bernardi, Pierpaolo Di Micco
Publikováno v:
Medicina, Vol 60, Iss 1, p 156 (2024)
Low-molecular-weight heparins are a class of drugs derived from the enzymatic depolymerization of unfractionated heparin that includes enoxaparin. Several studies have been performed on enoxaparin in recent years, in particular for the prevention and
Externí odkaz:
https://doaj.org/article/4f0256c8742c4eb1a7d083632708e55e
Autor:
Frank L. Dini, Erberto Carluccio, Roberto Bitto, Michele Ciccarelli, Michele Correale, Andreina D'Agostino, Giuseppe Dattilo, Marco Ferretti, Arianna Grelli, Stefania Guida, Francesca Jacoangeli, Laura Lupi, Lorenzo Luschi, Daniele Masarone, Valentina Mercurio, Giuseppe Pacileo, Nicola Riccardo Pugliese, Antonella Rispoli, Laura Scelsi, Carlo Gabriele Tocchetti, Natale Daniele Brunetti, Alberto Palazzuoli, Massimo Piepoli, Savina Nodari, Giuseppe Ambrosio, Working Group on Heart Failure of the Italian Society of Cardiology
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 1107-1117 (2022)
Abstract Aim Echo‐derived haemodynamic classification, based on forward‐flow and left ventricular (LV) filling pressure (LVFP) correlates, has been proposed to phenotype patients with heart failure and reduced ejection fraction (HFrEF). To assess
Externí odkaz:
https://doaj.org/article/83b376a129cc49e498ba19b0a1e42b29
Autor:
Matteo Casale, Maurizio Mezzetti, Marianna Gigliotti De Fazio, Loredana Caccamo, Paolo Busacca, Giuseppe Dattilo
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 146-154 (2022)
Abstract Aims Cardiac resynchronization therapy (CRT) for heart failure (HF) recently has shown optimal results by targeting electrically delayed sites in coronary sinus (CS) branches. However this purpose often cannot be reached because of unstable
Externí odkaz:
https://doaj.org/article/5ec88c5f0e434452bf13c944693b487c